Generic Pharmaceuticals
🇺🇸 FDA Page 2FDA news and analysis for pharmaceutical BD, investment, and market access · 4 articles on this page
Unlock global generic pharmaceutical market insights. Stay ahead with regulatory updates, competitive intelligence, and strategic analysis for BD and investment.
Showing 13–16 of 16 articles
Earlier
High impact NewsApr 25, 2026
FDA Begins Preparation for GDUFA IV Reauthorization: Generic Drug User Fee Program 2028-2032
FDA · 2 min
Dr. Laura BennettCritical impact NewsApr 23, 2026
Cipla Receives FDA Approval for First Generic Ventolin HFA (Albuterol Sulfate) - AB-Rated Therapeutic Equivalent
FDA · 2 min
Michael RiveraHigh impact NewsApr 15, 2026
Corbus Pharmaceuticals CRB-913 Obesity Drug Completes Patient Enrollment in CANYON-1 Phase 1b Trial
3 min
James Chen, PharmDHigh impact NewsApr 15, 2026
Apotex Receives FDA Approval for First Generic Infuvite Adult Injection with 180-Day Exclusivity
FDA · 2 min
James Chen, PharmDExplore intelligence